Glucose Awareness to Motivate and Enable Solutions (GAMES) in diabetes mellitus using flash glucose monitoring: A clinical programme

Aims This real‐world observational clinical programme evaluated short and medium‐term effects of intermittent flash glucose monitoring on HbA1c, glycaemic variability and lifestyle behavioural changes. Methods Two first‐generation Libre flash glucose monitoring sensors were provided 3–4 months apart...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Diabetic medicine 2022-01, Vol.39 (1), p.e14733-n/a
Hauptverfasser: Yeoh, Ester, Png, Doanna, Koh, Pei Ling, Sum, Chee Fang, Lim, Su Chi, Tan, Hwee Huan, Ubeynarayana, Chalani Udhyami, Subramaniam, Tavintharan
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page n/a
container_issue 1
container_start_page e14733
container_title Diabetic medicine
container_volume 39
creator Yeoh, Ester
Png, Doanna
Koh, Pei Ling
Sum, Chee Fang
Lim, Su Chi
Tan, Hwee Huan
Ubeynarayana, Chalani Udhyami
Subramaniam, Tavintharan
description Aims This real‐world observational clinical programme evaluated short and medium‐term effects of intermittent flash glucose monitoring on HbA1c, glycaemic variability and lifestyle behavioural changes. Methods Two first‐generation Libre flash glucose monitoring sensors were provided 3–4 months apart with a food, activity diary, user evaluation survey and treatment modification after each sensor wear. T‐tests were used to compare glucose variables within each sensor (week 1 vs. week 2) and between sensors (1st sensor vs. 2nd sensor). EasyGV software was used to calculate glycaemic variability. Results From 42 type 1 diabetes and 120 type 2 diabetes participants, there was no statistically significant change in mean HbA1c for participants with type 1 diabetes at 3–4 months after the 1st sensor but there was a statistically significant HbA1c reduction for participants with type 2 diabetes [−4 mmol/mol (−0.4%), p = 0.008], despite no statistically significant differences in carbohydrate intake, exercise frequency and duration. Greater reduction was seen in those with baseline HbA1c> 86 mmol/mol (10%) in both type 1 [−12 mmol/mol (−1.1%), p = 0.009] and type 2 diabetes [−11 mmol/mol (−1.0%), p = 0.001). Both type 1 and type 2 diabetes showed improvements in Glucose Management Indicator and percentage time‐above‐range when comparing week 1 versus week 2 of the same sensor. Higher scan frequency resulted in improved glycaemic parameters and certain measures of glycaemic variability. The majority of participants (85%) agreed that flash glucose monitoring is a useful device but only 60% were keen to use it for daily monitoring. Conclusion Constant feedback from flash glucose monitoring improves glycaemic parameters within the first week of wear. Intermittent use 3–4 months apart resulted in greater improvements for those with higher baseline HbA1c.
doi_str_mv 10.1111/dme.14733
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2586456930</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2611016913</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3533-b9e33966f4abdd6d5a98ec132d033a60f319b84083376c9eeea8a224fd5f68153</originalsourceid><addsrcrecordid>eNp1kbFuFDEQhi1ERI5AwQsgSzRJsYm94_Wt6U7hciDlRBGoLe969nDktYO9myg9D47JHRRImWaK-fTNL_2EvOPsnJe5sCOec7EEeEEWXEhRNULxl2TBlqKugC35MXmd8y1jvFagXpFjEFK1omYL8mvj5z5mpKsHkzBgznSKdBsnd28mpCZYug6m80hvop8nF0Omp5vVdn1zRl2g1pkOJ8x0RO_dNGc6Zxd2dPAm_6C7g3uMwU0xlcNHuqK9d8H1xtO7FHfJjCO-IUeD8RnfHvYJ-X61_nb5ubr-uvlyubquemgAqk4hgJJyEKazVtrGqBZ7DrVlAEayAbjqWsFagKXsFSKa1tS1GGwzyJY3cEJO997y-eeMedKjy31JbgLGOeu6aaVopAJW0A__obdxTqGk07XknHGpOBTqbE_1KeaccNB3yY0mPWrO9J9qdKlGP1VT2PcH49yNaP-Rf7sowMUeeHAeH5836U_b9V75G1ull_A</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2611016913</pqid></control><display><type>article</type><title>Glucose Awareness to Motivate and Enable Solutions (GAMES) in diabetes mellitus using flash glucose monitoring: A clinical programme</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Yeoh, Ester ; Png, Doanna ; Koh, Pei Ling ; Sum, Chee Fang ; Lim, Su Chi ; Tan, Hwee Huan ; Ubeynarayana, Chalani Udhyami ; Subramaniam, Tavintharan</creator><creatorcontrib>Yeoh, Ester ; Png, Doanna ; Koh, Pei Ling ; Sum, Chee Fang ; Lim, Su Chi ; Tan, Hwee Huan ; Ubeynarayana, Chalani Udhyami ; Subramaniam, Tavintharan</creatorcontrib><description>Aims This real‐world observational clinical programme evaluated short and medium‐term effects of intermittent flash glucose monitoring on HbA1c, glycaemic variability and lifestyle behavioural changes. Methods Two first‐generation Libre flash glucose monitoring sensors were provided 3–4 months apart with a food, activity diary, user evaluation survey and treatment modification after each sensor wear. T‐tests were used to compare glucose variables within each sensor (week 1 vs. week 2) and between sensors (1st sensor vs. 2nd sensor). EasyGV software was used to calculate glycaemic variability. Results From 42 type 1 diabetes and 120 type 2 diabetes participants, there was no statistically significant change in mean HbA1c for participants with type 1 diabetes at 3–4 months after the 1st sensor but there was a statistically significant HbA1c reduction for participants with type 2 diabetes [−4 mmol/mol (−0.4%), p = 0.008], despite no statistically significant differences in carbohydrate intake, exercise frequency and duration. Greater reduction was seen in those with baseline HbA1c&gt; 86 mmol/mol (10%) in both type 1 [−12 mmol/mol (−1.1%), p = 0.009] and type 2 diabetes [−11 mmol/mol (−1.0%), p = 0.001). Both type 1 and type 2 diabetes showed improvements in Glucose Management Indicator and percentage time‐above‐range when comparing week 1 versus week 2 of the same sensor. Higher scan frequency resulted in improved glycaemic parameters and certain measures of glycaemic variability. The majority of participants (85%) agreed that flash glucose monitoring is a useful device but only 60% were keen to use it for daily monitoring. Conclusion Constant feedback from flash glucose monitoring improves glycaemic parameters within the first week of wear. Intermittent use 3–4 months apart resulted in greater improvements for those with higher baseline HbA1c.</description><identifier>ISSN: 0742-3071</identifier><identifier>EISSN: 1464-5491</identifier><identifier>DOI: 10.1111/dme.14733</identifier><identifier>PMID: 34698420</identifier><language>eng</language><publisher>England: Wiley Subscription Services, Inc</publisher><subject>Adult ; Awareness ; Blood Glucose - metabolism ; blood glucose monitoring ; Blood Glucose Self-Monitoring - methods ; Diabetes ; diabetes mellitus ; Diabetes mellitus (insulin dependent) ; Diabetes mellitus (non-insulin dependent) ; Diabetes Mellitus, Type 1 - blood ; Diabetes Mellitus, Type 1 - diagnosis ; Diabetes Mellitus, Type 1 - drug therapy ; Diabetes Mellitus, Type 2 - blood ; Diabetes Mellitus, Type 2 - diagnosis ; Diabetes Mellitus, Type 2 - drug therapy ; Female ; flash glucose monitoring ; Glucose ; Glucose monitoring ; glucose sensors ; glycaemic variability ; Glycated Hemoglobin A - metabolism ; Humans ; Hypoglycemic Agents - therapeutic use ; Male ; Middle Aged ; Motivation ; Sensors ; Statistical analysis</subject><ispartof>Diabetic medicine, 2022-01, Vol.39 (1), p.e14733-n/a</ispartof><rights>2021 Diabetes UK</rights><rights>2021 Diabetes UK.</rights><rights>Diabetic Medicine © 2022 Diabetes UK</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3533-b9e33966f4abdd6d5a98ec132d033a60f319b84083376c9eeea8a224fd5f68153</citedby><cites>FETCH-LOGICAL-c3533-b9e33966f4abdd6d5a98ec132d033a60f319b84083376c9eeea8a224fd5f68153</cites><orcidid>0000-0002-3361-7512 ; 0000-0002-2686-9412</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fdme.14733$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fdme.14733$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27903,27904,45553,45554</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34698420$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Yeoh, Ester</creatorcontrib><creatorcontrib>Png, Doanna</creatorcontrib><creatorcontrib>Koh, Pei Ling</creatorcontrib><creatorcontrib>Sum, Chee Fang</creatorcontrib><creatorcontrib>Lim, Su Chi</creatorcontrib><creatorcontrib>Tan, Hwee Huan</creatorcontrib><creatorcontrib>Ubeynarayana, Chalani Udhyami</creatorcontrib><creatorcontrib>Subramaniam, Tavintharan</creatorcontrib><title>Glucose Awareness to Motivate and Enable Solutions (GAMES) in diabetes mellitus using flash glucose monitoring: A clinical programme</title><title>Diabetic medicine</title><addtitle>Diabet Med</addtitle><description>Aims This real‐world observational clinical programme evaluated short and medium‐term effects of intermittent flash glucose monitoring on HbA1c, glycaemic variability and lifestyle behavioural changes. Methods Two first‐generation Libre flash glucose monitoring sensors were provided 3–4 months apart with a food, activity diary, user evaluation survey and treatment modification after each sensor wear. T‐tests were used to compare glucose variables within each sensor (week 1 vs. week 2) and between sensors (1st sensor vs. 2nd sensor). EasyGV software was used to calculate glycaemic variability. Results From 42 type 1 diabetes and 120 type 2 diabetes participants, there was no statistically significant change in mean HbA1c for participants with type 1 diabetes at 3–4 months after the 1st sensor but there was a statistically significant HbA1c reduction for participants with type 2 diabetes [−4 mmol/mol (−0.4%), p = 0.008], despite no statistically significant differences in carbohydrate intake, exercise frequency and duration. Greater reduction was seen in those with baseline HbA1c&gt; 86 mmol/mol (10%) in both type 1 [−12 mmol/mol (−1.1%), p = 0.009] and type 2 diabetes [−11 mmol/mol (−1.0%), p = 0.001). Both type 1 and type 2 diabetes showed improvements in Glucose Management Indicator and percentage time‐above‐range when comparing week 1 versus week 2 of the same sensor. Higher scan frequency resulted in improved glycaemic parameters and certain measures of glycaemic variability. The majority of participants (85%) agreed that flash glucose monitoring is a useful device but only 60% were keen to use it for daily monitoring. Conclusion Constant feedback from flash glucose monitoring improves glycaemic parameters within the first week of wear. Intermittent use 3–4 months apart resulted in greater improvements for those with higher baseline HbA1c.</description><subject>Adult</subject><subject>Awareness</subject><subject>Blood Glucose - metabolism</subject><subject>blood glucose monitoring</subject><subject>Blood Glucose Self-Monitoring - methods</subject><subject>Diabetes</subject><subject>diabetes mellitus</subject><subject>Diabetes mellitus (insulin dependent)</subject><subject>Diabetes mellitus (non-insulin dependent)</subject><subject>Diabetes Mellitus, Type 1 - blood</subject><subject>Diabetes Mellitus, Type 1 - diagnosis</subject><subject>Diabetes Mellitus, Type 1 - drug therapy</subject><subject>Diabetes Mellitus, Type 2 - blood</subject><subject>Diabetes Mellitus, Type 2 - diagnosis</subject><subject>Diabetes Mellitus, Type 2 - drug therapy</subject><subject>Female</subject><subject>flash glucose monitoring</subject><subject>Glucose</subject><subject>Glucose monitoring</subject><subject>glucose sensors</subject><subject>glycaemic variability</subject><subject>Glycated Hemoglobin A - metabolism</subject><subject>Humans</subject><subject>Hypoglycemic Agents - therapeutic use</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Motivation</subject><subject>Sensors</subject><subject>Statistical analysis</subject><issn>0742-3071</issn><issn>1464-5491</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kbFuFDEQhi1ERI5AwQsgSzRJsYm94_Wt6U7hciDlRBGoLe969nDktYO9myg9D47JHRRImWaK-fTNL_2EvOPsnJe5sCOec7EEeEEWXEhRNULxl2TBlqKugC35MXmd8y1jvFagXpFjEFK1omYL8mvj5z5mpKsHkzBgznSKdBsnd28mpCZYug6m80hvop8nF0Omp5vVdn1zRl2g1pkOJ8x0RO_dNGc6Zxd2dPAm_6C7g3uMwU0xlcNHuqK9d8H1xtO7FHfJjCO-IUeD8RnfHvYJ-X61_nb5ubr-uvlyubquemgAqk4hgJJyEKazVtrGqBZ7DrVlAEayAbjqWsFagKXsFSKa1tS1GGwzyJY3cEJO997y-eeMedKjy31JbgLGOeu6aaVopAJW0A__obdxTqGk07XknHGpOBTqbE_1KeaccNB3yY0mPWrO9J9qdKlGP1VT2PcH49yNaP-Rf7sowMUeeHAeH5836U_b9V75G1ull_A</recordid><startdate>202201</startdate><enddate>202201</enddate><creator>Yeoh, Ester</creator><creator>Png, Doanna</creator><creator>Koh, Pei Ling</creator><creator>Sum, Chee Fang</creator><creator>Lim, Su Chi</creator><creator>Tan, Hwee Huan</creator><creator>Ubeynarayana, Chalani Udhyami</creator><creator>Subramaniam, Tavintharan</creator><general>Wiley Subscription Services, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>8FD</scope><scope>FR3</scope><scope>H94</scope><scope>K9.</scope><scope>P64</scope><scope>RC3</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-3361-7512</orcidid><orcidid>https://orcid.org/0000-0002-2686-9412</orcidid></search><sort><creationdate>202201</creationdate><title>Glucose Awareness to Motivate and Enable Solutions (GAMES) in diabetes mellitus using flash glucose monitoring: A clinical programme</title><author>Yeoh, Ester ; Png, Doanna ; Koh, Pei Ling ; Sum, Chee Fang ; Lim, Su Chi ; Tan, Hwee Huan ; Ubeynarayana, Chalani Udhyami ; Subramaniam, Tavintharan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3533-b9e33966f4abdd6d5a98ec132d033a60f319b84083376c9eeea8a224fd5f68153</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Adult</topic><topic>Awareness</topic><topic>Blood Glucose - metabolism</topic><topic>blood glucose monitoring</topic><topic>Blood Glucose Self-Monitoring - methods</topic><topic>Diabetes</topic><topic>diabetes mellitus</topic><topic>Diabetes mellitus (insulin dependent)</topic><topic>Diabetes mellitus (non-insulin dependent)</topic><topic>Diabetes Mellitus, Type 1 - blood</topic><topic>Diabetes Mellitus, Type 1 - diagnosis</topic><topic>Diabetes Mellitus, Type 1 - drug therapy</topic><topic>Diabetes Mellitus, Type 2 - blood</topic><topic>Diabetes Mellitus, Type 2 - diagnosis</topic><topic>Diabetes Mellitus, Type 2 - drug therapy</topic><topic>Female</topic><topic>flash glucose monitoring</topic><topic>Glucose</topic><topic>Glucose monitoring</topic><topic>glucose sensors</topic><topic>glycaemic variability</topic><topic>Glycated Hemoglobin A - metabolism</topic><topic>Humans</topic><topic>Hypoglycemic Agents - therapeutic use</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Motivation</topic><topic>Sensors</topic><topic>Statistical analysis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yeoh, Ester</creatorcontrib><creatorcontrib>Png, Doanna</creatorcontrib><creatorcontrib>Koh, Pei Ling</creatorcontrib><creatorcontrib>Sum, Chee Fang</creatorcontrib><creatorcontrib>Lim, Su Chi</creatorcontrib><creatorcontrib>Tan, Hwee Huan</creatorcontrib><creatorcontrib>Ubeynarayana, Chalani Udhyami</creatorcontrib><creatorcontrib>Subramaniam, Tavintharan</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Diabetic medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yeoh, Ester</au><au>Png, Doanna</au><au>Koh, Pei Ling</au><au>Sum, Chee Fang</au><au>Lim, Su Chi</au><au>Tan, Hwee Huan</au><au>Ubeynarayana, Chalani Udhyami</au><au>Subramaniam, Tavintharan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Glucose Awareness to Motivate and Enable Solutions (GAMES) in diabetes mellitus using flash glucose monitoring: A clinical programme</atitle><jtitle>Diabetic medicine</jtitle><addtitle>Diabet Med</addtitle><date>2022-01</date><risdate>2022</risdate><volume>39</volume><issue>1</issue><spage>e14733</spage><epage>n/a</epage><pages>e14733-n/a</pages><issn>0742-3071</issn><eissn>1464-5491</eissn><abstract>Aims This real‐world observational clinical programme evaluated short and medium‐term effects of intermittent flash glucose monitoring on HbA1c, glycaemic variability and lifestyle behavioural changes. Methods Two first‐generation Libre flash glucose monitoring sensors were provided 3–4 months apart with a food, activity diary, user evaluation survey and treatment modification after each sensor wear. T‐tests were used to compare glucose variables within each sensor (week 1 vs. week 2) and between sensors (1st sensor vs. 2nd sensor). EasyGV software was used to calculate glycaemic variability. Results From 42 type 1 diabetes and 120 type 2 diabetes participants, there was no statistically significant change in mean HbA1c for participants with type 1 diabetes at 3–4 months after the 1st sensor but there was a statistically significant HbA1c reduction for participants with type 2 diabetes [−4 mmol/mol (−0.4%), p = 0.008], despite no statistically significant differences in carbohydrate intake, exercise frequency and duration. Greater reduction was seen in those with baseline HbA1c&gt; 86 mmol/mol (10%) in both type 1 [−12 mmol/mol (−1.1%), p = 0.009] and type 2 diabetes [−11 mmol/mol (−1.0%), p = 0.001). Both type 1 and type 2 diabetes showed improvements in Glucose Management Indicator and percentage time‐above‐range when comparing week 1 versus week 2 of the same sensor. Higher scan frequency resulted in improved glycaemic parameters and certain measures of glycaemic variability. The majority of participants (85%) agreed that flash glucose monitoring is a useful device but only 60% were keen to use it for daily monitoring. Conclusion Constant feedback from flash glucose monitoring improves glycaemic parameters within the first week of wear. Intermittent use 3–4 months apart resulted in greater improvements for those with higher baseline HbA1c.</abstract><cop>England</cop><pub>Wiley Subscription Services, Inc</pub><pmid>34698420</pmid><doi>10.1111/dme.14733</doi><tpages>0</tpages><orcidid>https://orcid.org/0000-0002-3361-7512</orcidid><orcidid>https://orcid.org/0000-0002-2686-9412</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0742-3071
ispartof Diabetic medicine, 2022-01, Vol.39 (1), p.e14733-n/a
issn 0742-3071
1464-5491
language eng
recordid cdi_proquest_miscellaneous_2586456930
source MEDLINE; Wiley Online Library Journals Frontfile Complete
subjects Adult
Awareness
Blood Glucose - metabolism
blood glucose monitoring
Blood Glucose Self-Monitoring - methods
Diabetes
diabetes mellitus
Diabetes mellitus (insulin dependent)
Diabetes mellitus (non-insulin dependent)
Diabetes Mellitus, Type 1 - blood
Diabetes Mellitus, Type 1 - diagnosis
Diabetes Mellitus, Type 1 - drug therapy
Diabetes Mellitus, Type 2 - blood
Diabetes Mellitus, Type 2 - diagnosis
Diabetes Mellitus, Type 2 - drug therapy
Female
flash glucose monitoring
Glucose
Glucose monitoring
glucose sensors
glycaemic variability
Glycated Hemoglobin A - metabolism
Humans
Hypoglycemic Agents - therapeutic use
Male
Middle Aged
Motivation
Sensors
Statistical analysis
title Glucose Awareness to Motivate and Enable Solutions (GAMES) in diabetes mellitus using flash glucose monitoring: A clinical programme
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-23T19%3A27%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Glucose%20Awareness%20to%20Motivate%20and%20Enable%20Solutions%20(GAMES)%20in%20diabetes%20mellitus%20using%20flash%20glucose%20monitoring:%20A%20clinical%20programme&rft.jtitle=Diabetic%20medicine&rft.au=Yeoh,%20Ester&rft.date=2022-01&rft.volume=39&rft.issue=1&rft.spage=e14733&rft.epage=n/a&rft.pages=e14733-n/a&rft.issn=0742-3071&rft.eissn=1464-5491&rft_id=info:doi/10.1111/dme.14733&rft_dat=%3Cproquest_cross%3E2611016913%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2611016913&rft_id=info:pmid/34698420&rfr_iscdi=true